Table of content
Review Article | Vol. 7, Issue 1 | Journal of Orthopaedic Science and Research | Open Access

Non-Graft Related Failure Complications of Lateral Extra-articular Tenodesis with Anterior Cruciate Ligament Reconstruction: A Clinical Review


Laura CM Ndjonko1*ORCID iD.svg 1 , Julie Paska1, Samantha Watson1, Chetan Gohal2, Vehniah Tjong1


1Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

2Department of Orthopaedic Surgery, NYU Langone, New York, NY, USA


*Correspondence author: Laura CM Ndjonko, BA, Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; E-mail: [email protected]

Citation: Ndjonko LCM, et al. Non-Graft Related Failure Complications of Lateral Extra-articular Tenodesis with Anterior Cruciate Ligament Reconstruction: A Clinical Review. J Ortho Sci Res. 2026;7(1):1-17.


Copyright: © 2026 The Authors. Published by Athenaeum Scientific Publishers.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
License URL: https://creativecommons.org/licenses/by/4.0/

Received
28 December, 2025
Accepted
25 January, 2026
Published
01 February, 2026
Abstract

Many systematic reviews have extensively evaluated Anterior Cruciate Ligament (ACL) graft rupture in the setting of Lateral Extra-Articular Tenodesis (LET). However, other complications surrounding the addition of an LET may have been overlooked. This leads to a gap in the literature regarding the broader spectrum of LET complications, which underestimates a full understanding of its morbidity. This narrative review aims to fill this gap by synthesizing data from existing systematic reviews and using their primary studies in order to highlight non-graft related failure complications that were initially missed, such as hardware irritation, infections and hematoma. This study intends to provide a more comprehensive overview of non-graft failure complications for ACLR with LET that have been overlooked by previous reviews on this topic.

Keywords: Lateral Extra-Articular Tenodesis; Anterior Cruciate Ligament Reconstruction; Complications; Graft Failure; Systematic Review; Narrative Review


Introduction

Lateral Extra-Articular Tenodesis (LET) is a knee procedure that when alongside Anterior Cruciate Ligament Reconstruction (ACLR), has gained renewed interest for its ability to enhance rotational stability and reduce graft failure in high-risk patients [1]. LET is particularly appealing for athletes at high risk of reinjury and in particular, revision cases, as it has been shown to reduce graft failure rates and improve patient-reported outcomes [1]. Despite these benefits, the broader clinical picture and strict indications remain incomplete. Most systematic reviews to date have focused on binary success metrics such as graft success or return-to-play timelines-while giving limited attention to the full range of complications that may arise from LET [2-15]. This narrow focus risks underestimating the morbidity associated with the procedure. By examining the literature through a complication-centric lens, this study seeks to provide a more nuanced understanding of the risk profile associated with the addition of a LET. Our goal is to equip clinicians with a more balanced view one that includes both the biomechanical benefits and the potential complications that may influence outcomes.

The Significance of LET Complications

In recent years, ACL reconstruction has evolved from a purely mechanical reconstruction to a more holistic approach that considers joint kinematics, patient-specific risk factors and long-term joint health and rehabilitation [16]. The LET procedure has emerged as a helpful adjunct in this context, especially for younger patients with high-grade pivot shift or those undergoing revision ACLR [17]. Its biomechanical traits limiting internal tibial rotation and anterior translation-have been well supported in both cadaveric and clinical studies [18].

However, reinforcing the lateral structures of the knee is not without consequence. While the addition of a LET may reduce graft failure, it also introduces new sources of morbidity that are often underreported or inconsistently defined in the literature.

Methodology

A Narrative Review of Systematic Reviews

To explore the full spectrum of non-graft failure complications associated with LET, a narrative review was conducted by re-analyzing the primary studies included in existing systematic reviews and meta-analyses on the subject. This was done to show a possible lack of attention towards non-graft complications in LET literature, as well as to answer the question of what LET complications exist overall. The main outcome of our study is therefore to evaluate the non-graft complications that arise with LET-paired ACLR.

First, all systematic reviews that met the following inclusion criteria were identified: having LET performed with primary ACLR, reported clinical outcomes and included human subjects (Table 1). Exclusion criteria included studies unrelated to LET or ACLR, reviews that did not report outcomes, revision ACLR studies, as well as animal, cadaveric or purely biomechanical studies. Narrative reviews were also excluded to maintain methodological consistency.

Bias of all primary studies was assessed according to the Methodological Index for Non-Randomized Studies (MINORS) and the Revised Cochrane Risk-of-Bias Tool for Randomized Trials (RoB 2.0). The MINORS scale is out of 16 for non-comparative studies and 24 for comparative studies, where each item ranges from 0 to 2. The RoB 2.0 framework assesses the quality of randomized studies based on five domains: bias arising from the randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result. Each RoB 2.0 domain is rated as low risk, some concerns or high risk of bias.

Statistical Analysis

A single-factor Analysis of Variance (ANOVA) test was done, followed by the Tukey’s Honestly Significant Difference (HSD) test to obtain the p-values of all possible combinations of complication groups. The rationale of this testing was to determine the statistical significance of LET complications and whether certain ones were more prevalent than others for future clinical awareness.

First Author (Publication Year)

Study Design

LET Complications

N

Patient Age: Mean (SD) [Range] {N}, years

Graft Type

Sex Ratio (F:M)

Follow-Up Time: Mean (SD) [Range], months

Getgood 2020

RCT

Hematoma (3), ITB snapping (2), LET hardware removal (10), Overconstrained lateral compartment (1), Hardware irritation (14)

618

18.9

HT autograft

321:297

Not reported

Getgood 2019

RCT

Not reported

600

≤ 25

HT autograft

Not reported

Not reported

Anderson 2001

RCT

None

105

23.6 {35}, 22 {35}, 20.1 {35}

BPTB autograft, HT autograft

37:68

35.4 (11.6) [24-48]

Trichine 2014

RCT

None

120

33(14–56) {60}, 26(16–64) {60}

BPTB autograft

0:120

24

Rowan 2019

Pro cohort

Persistent numbness of the infrapatellar branches of the saphenous nerve (1)

273

33(14–56) {218}, 26(16–64) {55}

HT autograft

Not reported

Not reported

Gibbs 2021

Pro cohort

Not reported

20

20.8(6.8)

QT autograft, BTB autograft

Not reported

Not reported

Barber-Westin 1993

Pro cohort

Not reported

84

24 [14-38]

BPTB autograft

25:59

37

Noyes 1991

Pro cohort

Not reported

67

26 [16-48]

Not reported

27:40

Not reported

Vadala 2013

RCT

None

60

25 [15-40]

HT autograft

60:0

44.6

Porter 2020

RCT

None

40

20.7(1.8)

HT autograft

0:40

84

Castoldi 2020

RCT

Not reported

79

19.4 [19-20.2]

BPTB autograft

Not reported

Not reported

Zaffagnini 2006

RCT

None

75

29.5 [15-49]

BPTB autograft, HT autograft

26:49

60

Zaffagnini 2008

RCT

None

72

26 [19-45]

HT autograft

32:40

36

Giraud 2006

RCT

Not reported

63

27.1(7.5){34},  28.5(12) {29}

BPTB autograft

Not reported

Not reported

Dejour 2013

Pro cohort

Not reported

75

33.2 {25}, 27.5 {25}, 21.4 {25}

BPTB autograft, HT autograft

24:51

25

Ferretti 2016

Retro cohort

Septic arthritis (1)

139

27.3 [18-50] {71}, 25.7 [18-46] {68}

HT autograft

32:107

120

Strum 1989

Retro cohort

None

127

25.2 [16-42] {84}, 27.8 [17-57] {43}

BPTB autograft

Not reported

45.2 [24-90]

Wilson 2019

Retro case series

Not reported

60

13 [11-16]

HT autograft

21:36

38.5

Nishida 2022

RCT

Not reported

18

18.9(4.9) {9}, 22.0(8.8) {9}

QT autograft, BPTB autograft

7:11

Not reported

Sheean 2020

Pro cohort

Not reported

20

17.3 [15-24]

HT autograft, BPTB autograft, QT autograft

11:9

Not reported

Alessio-Mazzzola 2019

Retro case series

Not reported

22

23.8(4.2)

BPTB autograft

Not reported

42.2(16.9)

Grassi 2021

Retro case series

Deep infection (14), Superficial infection (16), Stiffness (6), Swelling (20)

22

22(4.5) {10}, 25.5(11) {10}

HT autograft

2:18

Not reported

Imbert 2017

Retro case series

None

7

Not reported

BPTB autograft

Not reported

Not reported

Colombet 2011

Retro cohort

Not reported

20

27.6(7.41) {10}, 27.43(7.8) {10}

HT autograft

3:17

Not reported

Meynard 2020

Retro case series

Granuloma on lateral scar (1), Neuroma near incision used to harvest hamstring tendons (1), Hypoesthesia on anterior side of tibia (2), Discomfort from interference screw near Gerdy’s tubercle (3), Pain behind thigh due to the hamstring tendon harvesting (1)

50

28.5(8.1)

Not reported

17:33

9.9(2)

Ahn 2021

Retro cohort

Limited flexion and pain from delayed protrusion of the bioabsorbable interference screw used for femoral fixation (1)

10

56.1(7.4)

HT autograft

5:5

Not reported

Cavaignac 2020

Pro cohort

Not reported

62

33.1(8.3) {31}, 27.2(6.7) {31}

HT autograft

Not reported

12

Kocher 2006

Retro case series

Not reported

44

10.3

Not reported

Not reported

63.6

Jorgensen 2001

Retro case series

Deep venous thromboembolism (1), Slight/moderate pain from lateral femoral hernia (9), Local irritation resulting in staple removal (48), Anterior knee pain during activity (15)

155

24

Not reported

37:117

Not reported

Green 2023

Retro case series

None

49

14.2(1)

QT autograft

21:27

24

Hantouly 2023

Retro cohort

Not reported

100

28.15

HT autograft, BPTB autograft

6:94

Not reported

Firth 2022

Case-control

Not reported

568

18.8

HT autograft

292:276

24

Perelli 2022

Retro  cohort

None

66

13.5(1.2)

HT autograft

Not reported

24

Mahmoud 2022

Retro cohort

Meniscus tears requiring a subsequent arthroscopy (3)

72

25(8.5)

HT autograft

17:55

10

El-Azab 2023

RCT

None

95

27(5.9) {48}, 28(6) {47}

Hamstring autograft

15:80

Not reported

Joseph 2020

Retro cohort

None

30

Not reported

HT autograft

5:25

Not reported

Eggeling 2022

Retro cohort

Not reported

78

32.3(10.6)

BPTB autograft, HT autograft, QT autograft

39:48

28.7 (8.8)

Minguell Monyart 2023

Pro case series

Anteroposterior instability (6), Knee pain (3), Graft re-rupture (1)

46

36.3(9.7)

Fresh frozen allografts

15:31

12

Viglietta 2022

Pro cohort

Not reported

161

28.4(6.4) {85}, 26.1(6) {79}

HT autograft

38:126

188.4

Marcacci 2009

Retro case series

Paresthesias in saphenous nerve distribution (4), Removal of staples (8)

60

Not reported

HT autograft

15:45

132

Monaco 2022

Retro cohort

Anterior knee pain (4), Symptomatic tibial tunnel cyst (1), Dysesthesia (3), Hemarthrosis (1), Growth disturbance (9)

111

16.2(1.4)

HT autograft

42:69

43.8 (17.6)

Declercq 2023

Retro case series

Graft re-rupture (3), Arthrofibrosis (1), Septic arthritis (1), Hematoma (1), Hardware irritation (1)

83

24.3

HT autograft

Not reported

67.7

Heard 2023

RCT

Infection (5), ITB snapping (2), Persistent effusion (10), Hardware removal (10), Stiffness (5), Hematoma (3), Periostitis (1)

618

18.9

HT autograft

316:302

Not reported

Farinelli 2023

Retro case series

Loose body from a cartilage injury of the patella (1)

27

23.2(4.3)

QT autograft, BPTB autograft

0:27

Not reported

Alm 2020

Retro case series

Not reported

111

30.1(12.2)

QT autograft, HT autograft, BPTB autograft

43:68

24

Jacquet 2021

Retro cohort

Not reported

266

30.4(8.4)

QT autograft, HT autograft, BPTB autograft

76:190

44.3

Keizer 2023

Retro cohort

Not reported

78

27.6(7.6){42}, 31.3(8.9) {36}

BPTB autograft

21:57

43.9 (29.2)

Borim 2023

Pro case series

Hemarthrosis (1), Residual pain (1), Material discomfort (2)

19

29.8(7.5)

BPTB autograft

10:0

24

Hoekstra 1986

Retro case series

Plaster ulcer of the heel (1), Superficial wound infection (1), Transient peroneal palsy due to compression (1), Urinary tract infection (2)

27

27.3

QT autograft

4:23

Not reported

Rackemann 1991

Retro case series

Loss of extension (17), loss of flexion (12), patellofemoral crepitus (12), mechanical clunk of snap (6), anterior knee pain (4), slight ache after use (4), persistent effusion (3), removal of wire/silk (3), intra-articular adhesion (3), Infection (2), removal of staple (1), late infection (1)

74

27.2

BPTB autograft

7:67

70

Johnston 2003

Retro cohort

Not reported

82

Not reported

Not reported

20:62

9.8 (3.2)

Aglietti 1992

Retro case series

None

120

Not reported

BPTB autograft, HT autograft

Not reported

24

Anderson 1994

Retro case series

Not reported

70

30 [22-60]

HT autograft

23:47

84

Yamaguchi 2006

Retro case series

Not reported

45

24.8

Not reported

13:32

Not reported

Lanzetti 2020

Retro case series

Unspecified complication (1)

42

12.5

HT autograft

12:30

96.1

Roberti di Sarsina 2019

Retro case series

Not reported

20

12.3(1.7)

HT autograft

10:10

54

Willimon 2015

Retro case series

None

21

11.8

Not reported

0:21

36

Kerschbaumer 1987

RCT

None

60

33.1

BPTB autograft

Not reported

34.8

Barrett 1995

Retro cohort

None

70

Not reported

BPTB autograft

Not reported

Not reported

Ferkel 1988

Retro cohort

Not reported

80

Not reported

Not reported

Not reported

[24-72]

Hefti 1982

Retro cohort

Not reported

87

27.3

QT autograft, BPTB autograft

Not reported

24

Kanisawa 2003

Retro cohort

Not reported

11

Not reported

HT autograft

2:9

18.7 (4.1)

Laffargue 1997

Retro cohort

Not reported

90

27

BPTB autograft, HT autograft

Not reported

12

Monaco 2007

Retro cohort

Not reported

20

Not reported

HT autograft

0:20

Not reported

O’Brien 1991

Retro cohort

Not reported

80

Not reported

BPTB autograft

21:59

48

Paterson 1986

Retro cohort

Wound infection (2), Residual flexion deformity (5)

40

25.4

BPTB autograft

Not reported

2.9

Sgaglione 1990

Retro cohort

None

70

Not reported

HT autograft

Not reported

38.5

Sonnery-Cottet 2011

Case-control

Not reported

50

35

Not reported

15:35

Not reported

Verdano 2012

Retro cohort

None

40

28.75

HT autograft

8:12

48

Pernin 2010

Retro case series

Not reported

100

22.9

BPTB autograft

Not reported

294

Porter 2018

Pro cohort

Superficial wound infection (1)

38

25.2(6.0)

HT autograft

20:18

24

Ventura 2021

Retro cohort

None

24

29.3(9.5) {12}, 31.4(10.3) {12}

HT autograft

5:19

4.5

Pro: Prospective; Retro: Retrospective; RCT: Randomized Controlled Trial; N: Number of patients; F: Females; M: Males; MO, Months; ITB: Iliotibial Band; HT: Hamstrings Tendon; BPTB: Bone-Patellar Tendon Bone; QT: Quadriceps Tendon

Table 1: Demographics of included primary studies on LET from the systematic review dataset.

Results

Search Criteria and Bias Assessment

Fourteen systematic reviews were found with the search terms “lateral extra-articular tenodesis, “anterior cruciate ligament,” “systematic review,” and “meta-analysis” [2-5]. Two reviewers (LN and SW) then extracted all primary studies from the fourteen systematic reviews, yielding a total of 72 unique articles (Table 1). The reviewers ensured all primary studies up to date were included, then screened all of the included articles to identify those with complications. Only 20 of the 72 studies (27.8%) met the criteria and were included in our final analysis of LET complications (Table 1).

The Cochrane and MINORS bias assessments showed that our randomized controlled trials and non-randomized controlled trials were determined to be at low risk of bias and of decent overall quality (see Appendices A and B).

Paper Demographics

In terms of paper demographics, the total number of patients identified in the included articles was N = 7,106, with sex ratios of female to male patients being reported in 51 of 72 studies (70.8%) (Table 1). Of the included papers that reported sex ratios, there were a total of 1,809 female patients and 3,101 male patients, leaving nearly 2,196 patients (30.9%) unidentifiable by biological sex (Table 1). The average age of participants in the included studies was heterogeneously reported. Twenty-six of 72 papers (36.1%) explicitly stated a mean and standard deviation that could be used to calculate a weighted mean age for the entire cohort. Using these papers, an average age of 26.47 [26.40-26.55] (CI = 95%) was calculated for the narrative review cohort (Table 1).

When LET was performed with ACLR, ACL graft type was another variable reported with diversity. Generally, the specific graft type used in the surgical procedure was reported in 63 of 72 papers (87.5%) (Table 1). Hamstring Tendon (HT) grafts seemed to be the most common, with 41 of 72 papers (56.9%) reporting the use of this graft (Table 1).. The second most common type of ACL graft in our narrative review was Bone Patellar Tendon Bone (BPTB) grafts, with 29 of 72 papers (40.2%) reporting the use of this graft among their participants (Table 1). One of the least popular graft types appeared to be Quadriceps Tendon (QT) grafts, with only 10 papers (13.9%) reporting the use of this graft (Table 1). Only 1 article reported the use of fresh frozen donor grafts (1.4%) and the anatomical origin of these donor grafts was indeterminable (Table 1).

The average follow-up time reported by included studies was also heterogeneously reported. Eight out of 72 papers (11.1%) did not report an average follow-up time after procedure. Not only this, but only 8 of 72 papers (11.1%) reported both an average follow-up time from procedure, along with a standard deviation that could be used to calculate a weighted mean follow-up for the narrative review cohort. Using the data available, a weighted average follow-up time of 31.05 [30.91-31.19] (CI = 95%) months was calculated for the cohort.

Of the 14 systematic reviews and meta-analyses found with our search terms, only 2 articles (14.3%) reported LET complications aside from graft failure. The remaining 12 articles (85.7%) did not report LET complications as a variable that the authors actively extracted or measured (Table 2).

Complications Summary

Analysis of complications reported from 22 included studies on Lateral Extra-Articular Tenodesis (LET) reveals four primary categories: hardware, irritation and chronic pain, motion loss and stiffness and infection and wound issues (Table 3). The last column of Table 3 further illustrates the p-value results of the ANOVA and HST test, allowing us to determine statistical significance. Hardware complications were the most frequently reported, affecting 76 patients (3.01% complication rate), including issues like LET hardware removal, discomfort from interference screws and local irritation from staples or wires. This rate was statistically significant compared to all other complications (p < 0.05). Following this were irritation and chronic pain, reported in 57 patients (2.26%), encompassing various pain types and mechanical symptoms, also significantly different from other complication categories. Motion loss and stiffness, observed in 46 patients (1.82%), included stiffness, loss of extension and flexion and arthrofibrosis. Lastly, infection and wound issues, affecting 37 patients (1.47%), comprised superficial and deep infections. These rates for motion loss and stiffness and infection and wound issues were statistically similar (p = 0.06) but different from the other two categories. Table 3 highlights all of the remaining complications and corresponding data.

SR-MA Study

Complications Beyond Graft Failure (Y/N)

Feng et al. (2022)2

N

Onggo et al. (2022)3

N

Park et al. (2023)4

Y

Na et al. (2021)5

N

Kolin et al. (2024)6

N

Zabrzynski et al. (2025)7

N

Ra et al. (2020)8

N

Carrozzo et al. (2023)9

N

Hewison et al. (2015)10

N

Devitt et al. (03/2017)11

N

Mao et al. (2021)12

N

Damayanthi et al. (2024)13

N

Boksh et al. (2024)14

Y

Devitt et al. (10/2017)15

N

ACLR: Anterior Cruciate Ligament Reconstruction; SR-MA: Systematic Review and Meta-Analyses; Y: yes; N: no.

Table 2: List of included systematic reviews and meta-analyses evaluating ACLR complications beyond graft failure.

Citation

Complication Type

Specific Complication

Total Patients per Complication Type (N)

Complication rates (%)

Significant (p < 0.05) compared to:

Getgood 2020,

Heard 2023,

Meynard 2020,

Ahn 2021,

Borim 2023,

Jorgensen 2001,

Marcacci 2009,

Declercq 2023,

Rackemann 1991

Hardware

LET hardware removal (10)

Discomfort from interference screw near Gerdy’s tubercle (3)

Pain from delayed protrusion of femoral screw (1)

Material discomfort (2)

Local irritation with staple removal (48)

Removal of staples (8)

Hardware irritation (1)

Removal of wire/silk (3)

76

3.011093502

All other complications

Getgood 2020,

Heard 2023

Jorgensen 2001

Rackemann 1991

Minguell Monyart 2023

Meynard 2020

Borim 2023

Irritation and chronic pain

Iliotibial band snapping (2)

Lateral femoral hernia pain (9)

Anterior knee pain during activity (15)

Anterior knee pain (4)

Knee pain (3)

Pain behind thigh from hamstring harvest (1)

Residual pain (1)

Slight ache after use (4)

Mechanical clunk or snap (6)

Patellofemoral crepitus (12)

57

2.258320127

All other complications

Grassi 2021

Rackemann 1991

Ahn 2021

Paterson 1986

Declercq 2023

Getgood 2020,

Heard 2023

Motion Loss and Stiffness

Stiffness (6)

Loss of extension (17)

Loss of flexion (12)

Limited flexion from screw protrusion (1)

Residual flexion deformity (5)

Intra-articular adhesion (3)

Arthrofibrosis (1)

Over-constrained lateral compartment (1)

46

1.822503962

All except: Infection and Wound Issues (p = 0.06)

Grassi 2021

Ferretti 2016,

Declercq 2023

Paterson 1986

Porter 2018,

Hoekstra 1986

Rackemann 1991

Infection and Wound Issues

Deep infection (14)

Superficial infection (16)

Septic arthritis (2)

Wound infection (2)

Superficial wound infection (2)

Late infection (1)

37

1.4659271

All except: Motion Loss and Stiffness (p = 0.06)

Getgood 2020

Heard 2023

Declercq 2023

Monaco 2022

Borim 2023

Grassi 2021

Rackemann 1991

Bleeding and Effusion

Hematoma (4)

Hemarthrosis (2)

Swelling (20)

Persistent effusion (3)

29

1.148969889

Hardware (p = 0.00), Irritation and chronic pain (p = 0.00), Motion Loss and Stiffness (p = 0.00), Infection and Wound Issues (p = 0.01), Miscellaneous (p = 0.01)

Minguell Monyart 2023

Minguell Monyart 2023

Declercq 2023

Mahmoud 2022

Monaco 2022

Farinelli 2023

Structural Instability

Anteroposterior instability (6)

Graft re-rupture (4)

Meniscus tear needing arthroscopy (3)

Symptomatic tibial tunnel cyst (1)

Loose body from patella cartilage injury (1)

15

0.5942947702

Hardware (p = 0.00), Irritation and chronic pain (p = 0.00), Motion Loss and Stiffness (p = 0.00), Infection and Wound Issues (p = 0.00)

Rowan 2019

Meynard 2020

Marcacci 2009

Monaco 2022

Hoekstra 1986

Neurological

Persistent numbness (saphenous nerve branches) (1)

Neuroma near hamstring harvest site (1)

Hypoesthesia on anterior tibia (2)

Paresthesias in saphenous nerve distribution (4)

Dysesthesia (3)

Transient peroneal palsy (1)

12

0.4754358162

Hardware (p = 0.00), Irritation and chronic pain (p = 0.00), Motion Loss and Stiffness (p = 0.00), Infection and Wound Issues (p = 0.00)

Jorgensen 2001

Hoekstra 1986

Meynard 2020

Hoekstra 1986

Lanzetti 2020

Miscellaneous

Deep venous thromboembolism (1)

Urinary tract infection (2)

Plaster ulcer (1)

Granuloma on lateral scar (1)

Plaster ulcer on heel (1)

Unspecified complication (1)

7

0.2773375594

Hardware (p = 0.00), Irritation and chronic pain (p = 0.00), Motion Loss and Stiffness (p = 0.00), Infection and Wound Issues (p = 0.00), Bleeding and Effusion (p = 0.01)

Table 3: Summary of LET complications from the 22 included studies reporting postoperative complications.

Discussion

While LET has demonstrated biomechanical benefits in reducing graft failure and improving rotational stability, its broader clinical impact is more complex [18]. A closer look at the literature reveals a range of complications that can meaningfully affect patient outcomes and satisfaction (Table 1). Previous systematic reviews on LET with ACLR largely overlooked the complication profile of this procedure and thus this narrative review re-evaluated the included literature in those reviews to better characterize the complications that were found but not reported. Among the 72 primary studies reviewed in this study, fewer than half reported LET-specific complications, suggesting that adverse outcomes may be nonexistent, underreported or inconsistently tracked. However, among the subset of studies that documented complications, the most common issues were hardware-related complaints, irritation and chronic pain, as well as motion loss and stiffness.

Hardware complications, with a total of 76 reported cases and a 3.01% complication rate, ranked as the most prevalent complication type for LET surgery in our study (Table 3). This aligns with the first complication listed in a recent systematic review on this topic, that instead looked at only 7 studies as opposed to the 22 studies included in this review [19]. The rate of hardware complications in this review demonstrated statistical significance when compared to all other reported complications (p < 0.05), suggesting its notable effect on LET surgery (Table 3). Hardware complications are clinically relevant as they can disrupt patient recovery and satisfaction by inducing pain, restricting movement and potentially necessitating further surgical intervention [19]. A study noted that metal staples used for LET fixation have been associated with increased irritation due to their potential prominence and friction [20]. To minimize hardware-related complications, careful selection of fixation devices may help. Studies have found advantages and disadvantages among biodegradable versus metallic screws. While biodegradable screws yield less infection risk and less localization irritation of the tissues, there is a higher likelihood for tunnel widening and joint effusion than seen with metal screws [21]. Further research into hardware selection and surgical techniques can help mitigate such complications following ACLR with LET.

The second most common complication in our study was irritation and chronic pain at the LET site. Among the patients who underwent ACLR with LET in our study, a total of 57 patients in 7 included studies reported postoperative pain or joint irritation (Table 3). This complication was reported by 2.26% of all included patients and statistically significantly different from all other reported complications (Table 3). To put these statistics into perspective, the literature indicates that the prevalence of post-operative pain ranges from 6.2% to 48.4% in ACLR patients [22]. The variability of reported pain experiences in the current literature suggests this topic may be understudied, which makes it difficult to isolate the role of LET in irritation and chronic pain for these patients. Additionally, due to heterogeneity in reporting irritation and chronic pain, such as the use of differing surveys or scales for pain measurement, it is not feasible to conclude that pain experiences are substantially different in the ACLR+LET group than the ACLR group alone. Future research should objectively and consistently evaluate pain levels in patients undergoing ACLR with and without LET to help determine its specific contribution to pain patterns post-operatively.

Motion loss and stiffness were the third most common complaints among patients who received ACLR with LET, corresponding to 1.82% of all complications reported in this study (Table 3). Additionally, this complication rate was found to be statistically significantly different from all other reported complications except for infection and wound issues (Table 3). The observed rate of mobility and stiffness-related complications among isolated ACLR patients is 1.5% and future comparative studies can be done to determine if there is a statistically significant difference between ACLR+LET cohorts, as these rates are fairly similar [23].

Limitations

A key challenge in understanding the true complication profile of Lateral Extra-Articular Tenodesis (LET) lies in the methodological inconsistencies across the literature. Systematic reviews, while valuable for summarizing large bodies of evidence, are only as robust as the studies they include. Unfortunately, many of the primary studies were heterogeneous, including varied study designs, sample sizes and limited follow-up durations.

Another limitation in standardization is in what different studies would constitute a complication. For example, some studies may classify postoperative stiffness as a complication, while others may consider it a normal part of recovery. While 20 primary articles allow a preliminary understanding of trends, the majority of the systematic review articles did not report LET complications. This limited our sample size and the ability to develop stronger claims about what LET complications exist overall.

Further limitations in the literature include the absence of reporting valuable variables in ACLR and LET procedures, such as sex ratios of included patients. As discussed previously, the sex ratios of female to male patients were unreported in 21 out of 72 papers (29.2%); not only this, but the overall narrative review cohort itself manifested a total sex ratio of 1,809:3,101 females to males. With 1.7x the number of included males than females, this ratio begs the question of how generalizable ACLR and LET procedural data are to the population with the highest prevalence of ACL injuries: females [24]. While women are anywhere from 2 to 8x more likely to acquire an ACL tear than their male counterparts, women comprised only 36.8% of the narrative review cohort [24]. Thus, a major limitation of the LET literature is the lack of female patient data inclusion, which is highly problematic given the abundance of ACL tears prevalent in females.

A similar statement can be made about the heterogeneity in reporting average follow-up time. While a weighted average follow-up time of 31.05 [30.91-31.19] (CI = 95%) months was calculated for the cohort, the limited reporting of follow-up times across the 72 primary studies (48 studies; 66.7%) reduces the credibility and trustworthiness of this statistic.

Future Directions: Moving Toward a More Complication-Aware Approach

As LET continues to gain traction as an adjunct to ACL reconstruction, future research may benefit from a shift toward more comprehensive and standardized evaluation of complications. Studies could move beyond graft survival as the dominant endpoint and instead prioritize complication profiles as primary outcomes. This approach might include systematic assessment of donor-site pain, sensory disturbances, hardware-related symptoms and functional limitations, allowing for a more transparent understanding of procedure-related morbidity. Additionally, stratifying complications by surgical technique remains an important unmet need. The primary studies reviewed (Table 1) did not specify whether complication rates differed by technique, despite substantial variability in LET procedures, including open versus minimally invasive approaches and differing fixation methods such as staples or suture anchors. Future investigations could aim to clarify whether certain techniques are associated with higher or lower complication burdens, which may help surgeons tailor operative decisions to individual patient risk profiles.

Long-Term Outcomes and Reporting Integrity

Long-term follow-up is also essential. Many LET complications, especially those related to joint degeneration or biomechanical over-constraint, may not become apparent until several years after surgery [27]. Studies with extended follow-up periods and radiographic assessments can help clarify whether LET contributes to chronic joint issues like osteoarthritis [27]. To continue, given the current lack of consistency and transparency in reporting, establishing a standard protocol for purporting follow-up time is crucial; future studies should maintain awareness of the loss of credibility and trustworthiness from inconsistent data reporting practices and the wide effects this has on generating statistics such as average follow-up time.

Lastly, it is also important to mention the lack of appropriate gender distribution in the literature. Given the heightened probability of ACL injuries in females than males, future studies should prioritize expanding honest reporting practices in sex ratios of data as well as actively and meaningfully including more members of at-risk populations in their research. Inclusivity is the key to valuable, generalizable data and ignoring this principle may lead to a lack of relevance and applicability of research findings.

Conclusion

While the LET effectively reduces graft failure when combined with ACLR, this narrative review highlights the rare complications that accompany this adjunct procedure. Hardware irritation, infections and hemorrhages emerged as the most common non-graft failure issues in this review. These findings note a need for more standardized, complication-aware research to support surgical decision-making for LET patients.

Conflict of Interest

The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Funding Statement

This research did not receive any specific grant from funding agencies in the public, commercial or non-profit sectors.

Acknowledgement

None.

Data Availability Statement

Not applicable.

Ethical Statement                                                

The project did not meet the definition of human subject research under the purview of the IRB according to federal regulations and therefore, was exempt.

Informed Consent Statement

Informed consent was taken for this study.

Authors’ Contributions

All authors contributed equally to this paper.

References
  1. Mahmoud A, Torbey S, Honeywill C, Myers P. Lateral extra-articular tenodesis combined with anterior cruciate ligament reconstruction is effective in knees with additional features of lateral, hyperextension or increased rotational laxity: A matched cohort study. Arthroscopy. 2022;38:119-24.
  2. Feng J, Cao Y, Tan L, Liang J, He C, He J, et al. Anterior cruciate ligament reconstruction with lateral extra-articular tenodesis reduces knee rotation laxity and graft failure rate: A systematic review and meta-analysis. J Orthop Surg (Hong Kong). 2022;30:10225536221095969.
  3. Onggo JR, Rasaratnam HK, Nambiar M, Onggo JD, Pai V, Damasena I, et al. Anterior cruciate ligament reconstruction alone versus with lateral extra-articular tenodesis with minimum 2-year follow-up: A meta-analysis and systematic review of randomized controlled trials. Am J Sports Med. 2022;50:1137-45.
  4. Park YB, Lee HJ, Cho HC, Pujol N, Kim SH. Combined lateral extra-articular tenodesis or combined anterolateral ligament reconstruction and anterior cruciate ligament reconstruction improves outcomes compared to isolated reconstruction for anterior cruciate ligament tear: A network meta-analysis of randomized controlled trials. Arthroscopy. 2023;39:758-776.e10.
  5. Na BR, Kwak WK, Seo HY, Seon JK. Clinical outcomes of anterolateral ligament reconstruction or lateral extra-articular tenodesis combined with primary ACL reconstruction: A systematic review with meta-analysis. Orthop J Sports Med. 2021;9:23259671211023099.
  6. Kolin DA, Apostolakos J, Fabricant PD, Jivanelli B, SATURN Study Group, Yen YM, et al. Knee flexion angle of fixation during anterolateral ligament reconstruction or lateral extra-articular tenodesis: A systematic review and meta-analysis of lateral extra-articular reinforcement techniques performed in conjunction with ACL reconstruction. Orthop J Sports Med. 2024;12:23259671241231254.
  7. Zabrzyński J, Kwapisz A, Erdmann J, Zabrzyńska M, Błachowski M, Ohla J, et al. Indications for lateral extra-articular tenodesis in anterior cruciate ligament reconstruction: A systematic review. Am J Sports Med. 2025;53:3635465241309282.
  8. Ra HJ, Kim JH, Lee DH. Comparative clinical outcomes of anterolateral ligament reconstruction versus lateral extra-articular tenodesis in combination with anterior cruciate ligament reconstruction: Systematic review and meta-analysis. Arch Orthop Trauma Surg. 2020;140:923-31.
  9. Carrozzo A, Monaco E, Saithna A, Annibaldi A, Guy S, Ferreira A, et al. Clinical outcomes of combined anterior cruciate ligament reconstruction and lateral extra-articular tenodesis procedures in skeletally immature patients: A systematic review from the SANTI Study Group. J Pediatr Orthop. 2023;43:24-30.
  10. Hewison CE, Tran MN, Kaniki N, Remtulla A, Bryant D, Getgood AM. Lateral extra-articular tenodesis reduces rotational laxity when combined with anterior cruciate ligament reconstruction: A systematic review of the literature. Arthroscopy. 2015;31:2022-34.
  11. Devitt BM, Bouguennec N, Barfod KW, Porter T, Webster KE, Feller JA. Combined anterior cruciate ligament reconstruction and lateral extra-articular tenodesis does not result in an increased rate of osteoarthritis: A systematic review and best evidence synthesis. Knee Surg Sports Traumatol Arthrosc. 2017;25:1149-60.
  12. Mao Y, Zhang K, Li J, Fu W. Supplementary lateral extra-articular tenodesis for residual anterolateral rotatory instability in patients undergoing single-bundle anterior cruciate ligament reconstruction: a meta-analysis of randomized controlled trials. Orthop J Sports Med. 2021;9:23259671211002282.
  13. Damayanthi ED, Kholinne E, Singjie LC, Sakti M, Anesstesia IJ. Combined anterior cruciate ligament reconstruction and lateral extra-articular tenodesis through the modified Lemaire technique versus isolated ACL reconstruction: A meta-analysis of clinical outcomes. Rev Bras Ortop (Sao Paulo). 2024;59:e180-8.
  14. Boksh K, Sheikh N, Chong HH, Ghosh A, Aujla R. The role of anterolateral ligament reconstruction or lateral extra-articular tenodesis for revision anterior cruciate ligament reconstruction: A systematic review and meta-analysis of comparative clinical studies. Am J Sports Med. 2024;52:269-85.
  15. Devitt BM, Bell SW, Ardern CL, Hartwig T, Porter TJ, Feller JA, et al. The role of lateral extra-articular tenodesis in primary anterior cruciate ligament reconstruction: A systematic review with meta-analysis and best-evidence synthesis. Orthop J Sports Med. 2017;5:2325967117731767.
  16. Schmitz RJ, Ford KR, Pietrosimone B, Shultz SJ, Taylor JB. ACL Research Retreat IX summary statement: The pediatric athlete, March 17-19, 2022; High Point, North Carolina. J Athl Train. 2022;57:990-5.
  17. Jones EN, Post HK, Stovall BA, Ierulli VK, Vopat BG, Mulcahey MK. Lateral extra-articular tenodesis augmentation of anterior cruciate ligament reconstruction is most commonly indicated for pivot shift of grade 2 or greater and for revision anterior cruciate ligament reconstruction. Arthroscopy. 2024;40:2624-32.
  18. Nazzal EM, Keeling LE, Ryan PM, Herman ZJ, Hughes JD. The role of lateral extra-articular tenodesis in anterior cruciate ligament reconstruction and treatment of rotatory knee instability: A scoping review. Curr Rev Musculoskelet Med. 2023;16:235-45.
  19. Zabrzyński J, Erdmann J, Zabrzyńska M, Łapaj Ł, Malik SS, Kwapisz A. Are there any complications after lateral extra-articular tenodesis in anterior cruciate ligament reconstruction? A systematic review. J Orthop Surg Res. 2025;20:451.
  20. Momaya A, Harris C, Hargreaves M. Why your patient may need an ACL reconstruction plus lateral extra-articular tenodesis procedure. Int J Sports Phys Ther. 2024;19:251-7.
  21. Ramos DM, Dhandapani R, Subramanian A, Sethuraman S, Kumbar SG. Clinical complications of biodegradable screws for ligament injuries. Mater Sci Eng C Mater Biol Appl. 2020;109:110423.
  22. Baez S, Harkey M, Birchmeier T, Triplett A, Collins K, Kuenze C. Psychological readiness, injury-related fear and persistent knee symptoms after anterior cruciate ligament reconstruction. J Athl Train. 2023;58:998-1003.
  23. Yamani A-MM, Shari NF, Abushahot MA, Omor AF, Alannaz NA. Knee stiffness post anterior cruciate ligament reconstruction: Factors to worry about. Int J Res Orthop. 2023;9:913-7.
  24. The female ACL: Why is it more prone to injury? J Orthop. 2016;13:A1-4.
  25. Darville GL, Young BL, Lamplot JD, Xerogeanes JW. Arthroscopic-assisted lateral extra-articular tenodesis with knotless anchor fixation. Arthrosc Tech. 2023;12:e2257-64.
  26. Moran TE, MacLean IS, Anderson GR, Barras LA, Graf RM, Diduch DR, et al. Lateral extra-articular tenodesis staple risks penetration of anterior cruciate ligament reconstruction tunnel. Arthrosc Sports Med Rehabil. 2022;5:e193-200.
  27. Lucidi GA, Agostinone P, Di Paolo S, Dal Fabbro G, Serra M, Viotto M, et al. Long-term outcomes after anterior cruciate ligament reconstruction with three different surgical techniques: A prospective randomized clinical and radiographic evaluation at a minimum of 20 years’ follow-up. Orthop J Sports Med. 2025;13:23259671241302348.

Appendix

Appendix A: Cochrane risk of bias 2.0 assessment for 14 Randomized Controlled Trials (RCTs) included in this study.

Appendix B: MINORS risk of bias assessment for the 58 non-randomized studies included in this study.

Laura CM Ndjonko1*ORCID iD.svg 1 , Julie Paska1, Samantha Watson1, Chetan Gohal2, Vehniah Tjong1


1Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

2Department of Orthopaedic Surgery, NYU Langone, New York, NY, USA


*Correspondence author: Laura CM Ndjonko, BA, Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; E-mail: [email protected]

Copyright: © 2026 The Authors. Published by Athenaeum Scientific Publishers.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
License URL: https://creativecommons.org/licenses/by/4.0/

Citation: Ndjonko LCM, et al. Non-Graft Related Failure Complications of Lateral Extra-articular Tenodesis with Anterior Cruciate Ligament Reconstruction: A Clinical Review. J Ortho Sci Res. 2026;7(1):1-17.

Crossmark update

Article Metrics

Share this article: